hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 8.10
0.00 (0.00%)
May 26, 2026, 4:37 PM GMT
hVIVO Market Cap
hVIVO has a market cap or net worth of 55.65 million as of May 26, 2026. Its market cap has decreased by -55.31% in one year.
Market Cap
55.65M
Enterprise Value
56.14M
Revenue
49.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.10
Market Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 55.65M, an increase of 222.83%. That is a compound annual growth rate of 18.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 55.65M | 29.83% |
| Dec 31, 2025 | 42.86M | -69.27% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioventix | 87.52M |
| Faron Pharmaceuticals Oy | 82.80M |
| Ondine Biomedical | 77.93M |
| 4basebio | 75.07M |
| Hemogenyx Pharmaceuticals | 46.92M |
| Poolbeg Pharma | 35.54M |
| Sareum Holdings | 28.41M |
| ImmuPharma | 26.83M |